BRIACELL THERAPEUTICS CORP
Philadelphia, PA · CIK 0001610820 · Biotech · Public
Targeted immunotherapy treatments for cancer
briacell.com →- Grants
- $1.5M
- 2 awards
- Sector median: 1
- Raised
- $34M
- 4 Form D · Jun 2021
- 64 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 13
- 1 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $299,301 | |
| Private capital raised | Form D · SEC | $6,006,150 | |
| Private capital raised | Form D · SEC | $800,000 | |
| Private capital raised | Form D · SEC | $27,195,924 | |
| Federal grant | Department of Health and Human Services · Phase I · An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors | $399,918 | |
| Federal grant | Department of Health and Human Services · Phase II · An Off-the-Shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic prostate cancer. | $1,106,781 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2112 | APC BIO INNOVATIONS INC | — | — |
| 2113 | ABILITY DYNAMICS, L.L.C. | — | $1.5M |
| 2114 | REPRODUCTIVE STRESS; MEASUREMENT, MECHANISMS AND MANAGEMENT, CORPORATION | — | — |
| 2115 | BRIACELL THERAPEUTICS CORP | — | $34M |
| 2116 | General Folders Inc. | — | $20K |
| 2117 | Renasant Bio | — | $55M |
| 2118 | PIXIMUNE, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Saeid BabaeiDirector
- Saeid BabeiDirector
- Jamieson BondarenkoDirector · Executive Officer
- Vaughn Embro-PantalonyDirector
- Bev FunstonDirector · Executive Officer
- Chris HealeyDirector
- Gadi LevinExecutive Officer
- Isaac MareskyDirector
- Martin SchmiegDirector
- Rahoul SharanDirector · Executive Officer
- Rebecca TaubDirector
- Jevin WerbesDirector · Executive Officer
- William WilliamsDirector · Executive Officer
- Charles WisemanDirector · Executive Officer
- Matthew WrightExecutive Officer
Patents
- Cancer Vaccines And Methods Of Use Thereofapplication
- Whole-cell Cancer Vaccines And Methods For Selection Thereofapplication
- Whole-cell Cancer Vaccines And Methods For Selection Thereofgranted
- Cancer Vaccines Expressing Post-translational Modified Antigens And Methods Of Use Thereofapplication
- Cancer Vaccines And Methods Of Use Thereofapplication
- Cancer Vaccines And Methods Of Use Thereofapplication
- Cancer Vaccines And Methods Of Use Thereofapplication
- Whole-cell Cancer Vaccines And Methods For Selection Thereofapplication
- Companion Diagnostics For Whole-cell Cancer Vaccineapplication
- Cancer Vaccines Expressing Post-translational Modified Antigens And Methods Of Use Thereofapplication
- Methods For Enhancing The Immunogenicity Of Cellular Vaccinesapplication
- Cancer Vaccines Expressing Post-translational Modified Antigens And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.